A Major Shareholder at Flex Pharma (FLKS) is Selling Shares

Today, a Major Shareholder at Flex Pharma (NASDAQ: FLKS), Christoph Westphal, sold shares of FLKS for $2.92M.

This is Westphal’s first Sell trade following 24 Buy transactions. In addition to Christoph Westphal, one other FLKS executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Currently, Flex Pharma has an average volume of 1.58M.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development.